Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  DietMedicationAging & DiabetesIssue 671

Metformin May Slow Aging Process

Worms treated with metformin live longer. The drug may slow the aging process by mimicking the effects of dieting....
Advertisement

A recent study grew Caenorhabditis elegans worms in the presence of E.Coli bacteria and observed the effects of metformin on the aging process. The results showed the worms that were treated with metformin had lived longer when the E.Coli strain was sensitive to the medication. In fact, the metformin increased their lifespan by 6 days, which is one-third of their usual life expectancy.

The way that metformin slows the aging process is by changing the metabolism process in the bacteria. By doing so, the bacteria restrict the nutrients that are available to the worm. This process has a similar effect to diet restriction in the body.

To isolate the metabolic pathways affected by metformin, the researchers included strains of E.Coli that had defective genes linked to metabolism and controlled the levels of nutrients available to the bacteria. The results revealed that metformin disturbed the bacteria's metabolism of folate and methionine. These are both building blocks to protein and any disruption can limit the nutrients that are available to the worm. This decrease in nutrients available to the host mimics diet restriction and allows the worm to live longer. However, when the worm was given excess sugar in its diet, the metformin did not delay the aging process.

In the gut, bacteria play an important role in nutrient digestion from food. Metabolic diseases including obesity, diabetes, inflammatory bowel disease, and cancer have been associated with defective gut bacteria. Even though metformin's anti-aging mechanism has not been proven in humans, this study may lead to future ways of preventing metabolic diseases.

Metformin Retards Aging in C. elegans by Altering Microbial Folate and Methionine Metabolism. Cell, 2013; 153 (1): 228 DOI: 10.1016/j.cell.2013.02.035 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 05 April, 2013 and appeared in  DietMedicationAging & DiabetesIssue 671

Past five issues: Diabetes Clinical Mastery Series Issue 216 | Issue 756 | Diabetes Clinical Mastery Series Issue 215 | SGLT-2 Inhibitors Special Edition November 2014 | Issue 755 |

2014 Most Popular Articles:

New SGLT2 Inhibitor Likely To Be Approved for Type 2 Diabetes
Posted November 14, 2014
New Approach Targets Type 2's Poorly Controlled With Metformin
Posted November 14, 2014
Grapefruit Juice May Affect Insulin Resistance
Posted October 23, 2014
Very Low Carbohydrate, Low Saturated Fat Diet for Type 2 Diabetes Management
Posted November 07, 2014
Dietary Magnesium Intake's Role in Decreasing Metabolic Syndrome
Posted October 31, 2014
Exercise Promotes Preservation of Beta Cells
Posted November 14, 2014
Handbook of Diabetes, 4th Ed., Excerpt #16: Diabetic Neuropathy
Posted November 02, 2014
FDA Accepts Filing of NDA for Empagliflozin/Metformin Fixed-dose Combination
Posted October 23, 2014
What's Hiding in that Insulin Box?
Posted October 27, 2014
Interview with NuSirt CEO Joe Cook, Jr: Improving Metformin Treatment, Part 1
Posted November 02, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
If the U.S. Affordable Care Act is reversed in the new congress, what impact will that have on your patients?
CME/CE of the Week
Jeffrey Mechanick

Category: General Diabetes
Credits: .75
Search Articles On Diabetes In Control